Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Material Requirements to Support Gene Therapy Development Clare Blue, Director of Analytical Development at Biogen and James Wilkinson, VP of Sales and Customer Success at Refeyn Manufacturing processes for gene therapy products are generally low yielding compared to production processes for other biologics. The material requir... May 19, 2022 2:00pm Just in Time Release of CAR T Cell Therapies During Covid-19 Irving Ford at Bristol Myers Squibb and Lori Daane at bioMérieux Presented by Irving Ford, Site QA Head multi-product CAR T facility at Bristol Myers Squibb 1 month ago | 78 mins CMC Progression from Early to Late Phase... Sarah Thomas, Vice President of Quality at REGENXBIO Inc. and Joanna Zmurko, NGS specialist at PathoQuest Full Title: CMC Progression from Early to Late Phase – Practical Considerations for Gene Therapy The principles for developing traditional biologics ... 2 months ago | 88 mins Regulatory Strategies For Rapid Sterility Testing... Dr. Michael J. Miller, at Microbiology Consultants, LLC and Lori Daane, at bioMérieux Full Title: Regulatory Strategies For Rapid Sterility Testing of Gene and Cell Therapy Products The need to utilize rapid sterility testing is gainin... 2 months ago | 122 mins A Successful Journey to Cell Therapy Manufacturing: From R&D to Lot-Release Kasey Kime, Sean Chang, Uma Lakshmipathy Cell therapy is a transformative cancer treatment that utilizes genetically modified cells from a healthy donor or patient's own immune system to atta... 10 months ago | 45 mins GMP Ancillary Materials for Cell & Gene Therapy Manufacturing: What to Consider Kasey Kime, Eric Roos This webinar covers regulatory requirements for GMP ancillary materials and the importance of regulatory documentation and support. Considerations for... 10 months ago | 43 mins Just in Time Release of CAR T Cell Therapies During Covid-19 Irving Ford at Bristol Myers Squibb and Lori Daane at bioMérieux Presented by Irving Ford, Site QA Head multi-product CAR T facility at Bristol Myers Squibb 6 months ago | 78 mins Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release... John Duguid, Executive Director, Research & Development at Vericel Corporation Full Title: Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release: Five-Year Review November 1, 2022 2:00pm Enabling Scalable & Cost-Effective Point of Care for Cell & Gene Therapies Qasim Rafiq, Xavier de Mollerat du Jeu, Sean Chang The transformative potential to change the way human disease is treated using cell and gene therapy has motivated rapid technological advancements tow... 10 months ago | 62 mins Building the Future of Labs: Adopting New Technologies to Navigate Change Sandra Colner, Global Head of Labs and Life Sciences Vertical, Intel; Paul Dobson, Head of Data, ValitaCell The biopharmaceutical industry is undergoing a digital transformation with AI at the forefront, driving innovation and enhancing business models. AI h... 4 months ago | 22 mins Load more
